An Adult Spasticity Registry of OnabotulinumtoxinA Treatment
Status:
Completed
Trial end date:
2017-10-09
Target enrollment:
Participant gender:
Summary
This is a registry study in adults with spasticity to determine onabotulinumtoxinA use in
clinical practice. Treatment will be administered in accordance with physician standard
practice. All treatment decisions lie with the physician.
Details
Lead Sponsor:
Allergan
Treatments:
abobotulinumtoxinA Botulinum Toxins Botulinum Toxins, Type A incobotulinumtoxinA onabotulinumtoxinA